Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Indian Price Freeze Tweak Sets Stage For Another Clash?

This article was originally published in Scrip

Executive Summary

India's National Pharmaceutical Pricing Authority (NPPA) appears to have made an unusual clarification aimed at freezing prices of new non-scheduled formulations – drugs which don't figure in the country's national list of essential medicines (NLEM) - setting the stage for another potential clash with industry over the legality of the move.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064944

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel